Dihydrotestosterone treatment delays the conversion from mild cognitive impairment to Alzheimer's disease in SAMP8 mice

Hormones and Behavior

Volumn 65, Issue 5, 2014, Pages 505-515

  Kang, Lin ^a   Li, Sha ^a   Xing, Zhaoguo ^a   Li, Jianzhong ^a   Su, Yuhong ^a   Fan, Ping ^a   Wang, Lei ^a   Cui, Huixian ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Hebei Key Laboratory for Brain Aging and Cognitive Neuroscience   (China)

Author keywords

Alzheimer's disease; Dihydrotestosterone; Mild cognitive impairment; SAMP8; Testosterone

Indexed keywords

ANDROGEN; ANDROSTANOLONE; TESTOSTERONE;

ADULT; AGE DISTRIBUTION; ALZHEIMER DISEASE; ANDROGEN BLOOD LEVEL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; EVENING DOSAGE; HORMONAL THERAPY; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; MOUSE; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SENESCENCE; AGING; ANIMAL; BLOOD; BRAIN; DRUG EFFECTS; FEMALE; HIPPOCAMPAL CA1 REGION; MALE; MAZE TEST; PATHOLOGY; PHYSIOLOGY; PSYCHOLOGY; SPECIES DIFFERENCE;

AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; CA1 REGION, HIPPOCAMPAL; DIHYDROTESTOSTERONE; DISEASE PROGRESSION; FEMALE; MALE; MAZE LEARNING; MICE; MILD COGNITIVE IMPAIRMENT; SPECIES SPECIFICITY; TESTOSTERONE;

EID: 84899873130     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2014.03.017     Document Type: Article

References (72)

1. Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C., Gamst A., Holtzman D.M., Jagust W.J., Petersen R.C., Snyder P.J., Carrillo M.C., Thies B., Phelps C.H. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:270-279.
2. Alzheimer's Association Alzheimer's disease facts and figures. Alzheimers Dement. 2012, 8:131-168.
3. Apostolova L.G., Mosconi L., Thompson P.M., Green A.E., Hwang K.S., Ramirez A., Mistur R., Tsui W.H., de Leon M.J. Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal. Neurobiol. Aging 2010, 31:1077-1088.
4. Baulieu E.E., Robel P. Dehydroepiandrosterone (DHEA) and dehydroepiandrosterone sulfate (DHEAS) as neuroactive neurosteroids. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:4089-4091.
5. Butterfield D.A., Poon H.F. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Exp. Neurol. 2005, 40:774-783.
6. Chen G.H., Wang Y.J., Qin S., Yang Q.G., Zhou J.N., Liu R.Y. Age-related spatial cognitive impairment is correlated with increase of synaptotagmin 1 in dorsal hippocampus in SAMP8 mice. Neurobiol. Aging 2007, 28:611-618.
7. Cherrier M.M., Craft S., Matsumoto A.H. Cognitive changes associated with supplementation of testosterone or dihydrotestosterone in mildly hypogonadal men: a preliminary report. J. Androl. 2003, 24:568-576.
8. Cherrier M.M., Matsumoto A.M., Amory J.K., Ahmed S., Bremner W., Peskind E.R., Raskind M.A., Johnson M., Craft S. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology 2005, 64:290-296.
9. Cherrier M.M., Matsumoto A.M., Amory J.K., Asthana S., Bremner W., Peskind E.R., Raskind M.A., Craft S. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology 2005, 64:2063-2068.
10. Coleman P.D., Yao P.J. Synaptic slaughter in Alzheimer's disease. Neurobiol. Aging 2003, 24:1023-1027.
11. DeCarli C. Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol. 2003, 2:15-21.
12. DeKosky S.T., Scheff S.W., Styren S.D. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 1996, 5:417-421.
13. Del Valle J., Duran-Vilaregut J., Manich G., Casadesús G., Smith M.A., Camins A., Pallàs M., Pelegrí C., Vilaplana J. Early amyloid accumulation in the hippocampus of SAMP8 mice. J. Alzheimers Dis. 2010, 19:1303-1315.
14. Flood J.F., Morley J.E. Early onset of age-related impairment of aversive and appetitive learning in the SAM-P/8 mouse. J. Gerontol. Biol. Sci. 1992, 47:B52-B59.
15. Flood J.F., Morley J.E. Learning and memory in the SAMP8 mouse. Neurosci. Biobehav. Rev. 1998, 22:1-20.
16. Flood J.F., Farr S., Kaiser F.E., La Regina M., Morley J.E. Age-related decrease of plasma testosterone in SAMP8 mice: replacement improves age-related impairment of learning and memory. Physiol. Behav. 1995, 57:669-673.
17. Flood J.F., Morley P.M., Morley J.E. Age-related changes in learning, memory, and lipofuscin as a function of the percentage of SAMP8 genes. Physiol. Behav. 1995, 58:819-822.
18. Geerlings M.I., Strozyk D., Masaki K., Remaley A.T., Petrovitch H., Ross G.W., White L.R., Launer L.J. Endogenous sex hormones, cognitive decline, and future dementia in old men. Ann. Neurol. 2006, 60:346-355.
19. Giannoulis M.G., Martin F.C., Nair K.S., Umpleby A.M., Sonksen P. Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?. Endocr. Rev. 2012, 33:314-377.
20. Grundman M., Petersen R.C., Ferris S.H., Thomas R.G., Aisen P.S., Bennett D.A., Foster N.L., Jack C.R., Galasko D.R., Doody R., Kaye J., Sano M., Mohs R., Gauthier S., Kim H.T., Jin S., Schultz A.N., Schafer K., Mulnard R., van Dyck C.H., Mintzer J., Zamrini E.Y., Cahn-Weiner D., Thal L.J. Mild cognitive impairment can be distinguished from Alzheimer diseases and normal aging for clinical trials. Arch. Neurol. 2004, 61:59-66.
21. Hojo Y., Hattori T.A., Enami T., Furukawa A., Suzuki K., Ishii H.T., Mukai H., Morrison J.H., Janssen W.G., Kominami S., Harada N., Kimoto T., Kawato S. Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:865-870.
22. Holland J., Bandelow S., Hogervorst E. Testosterone levels and cognition in elderly men: a review. Maturitas 2011, 69:322-337.
23. Hosokawa M., Kasai R., Higuchi K., Takeshita S., Shimizu K., Hamamoto H., Honma A., Irino M., Toda K., Matsumura A. Grading score system: a method for evaluation of the degree of senescence in Senescence Accelerated Mouse (SAM). Mech. Ageing Dev. 1984, 26:91-102.
24. Ishii H., Tsurugizawa T., Ogiue-Ikeda M., Asashima M., Mukai H., Murakami G., Hojo Y., Kimoto T., Kawato S. Local production of sex hormones and their modulation of hippocampal synaptic plasticity. Neuroscientist 2007, 13:323-334.
25. Jack C.R., Albert M.S., Knopman D.S., McKhann G.M., Sperling R.A., Carrillo M.C., Thies B., Phelps C.H. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:257-262.
26. Jonasson Z. Meta-analysis of sex differences in rodent models of learning and memory: a review of behavioral and biological data. Neurosci. Biobehav. Rev. 2005, 28:811-825.
27. Kenny A.M., Fabregas G., Song C., Biskup B., Bellantonio S. Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J. Gerontol. A Biol. Sci. Med. Sci. 2004, 59:75-78.
28. Kril J.J., Hodges J., Halliday G. Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without Alzheimer's disease. Neurosci. Lett. 2004, 361:9-12.
29. Kumar V.B., Farr S.A., Flood J.F., Kamlesh V., Franko M., Banks W.A., Morley J.E. Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice. Peptides 2000, 21:1769-1775.
30. Li S., Kang L., Zhang C., Xie G., Li N., Zhang Y., Du J., Cui H. Effects of dihydrotestosterone on synaptic plasticity of hippocampus in male SAMP8 mice. Exp. Gerontol. 2013, 48:778-785.
31. Linn M.C., Petersen A.C. Emergence and characterization of sex differences in spatial ability: a meta-analysis. Child Dev. 1985, 56:1479-1498.
32. Lu P.H., Masterman D.A., Mulnard R., Cotman C., Miller B., Yaffe K., Reback E., Porter V., Swerdloff R., Cummings J.L. Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch. Neurol. 2006, 63:177-185.
33. Maggio M., Dall'Aglio E., Lauretani F., Cattabiani C., Ceresini G., Caffarra P., Valenti G., Volpi R., Vignali A., Schiavi G., Ceda G.P. The hormonal pathway to cognitive impairment in older men. J. Nutr. Health Aging 2012, 16:40-54.
34. Martin S.J., Grimwood P.D., Morris R.G. Synaptic plasticity and memory: an evaluation of the hypothesis. Annu. Rev. Neurosci. 2000, 23:649-711.
35. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:263-269.
36. Miyamoto M., Kiyota Y., Yamazaki N., Nagaoka A., Matsuo T., Nagawa Y., Takeda T. Age-related changes in learning and memory in the Senescence-Accelerated Mouse (SAM). Physiol. Behav. 1986, 38:399-409.
37. Moffat S.D., Zonderman A.B., Metter E.J., Kawas C., Blackman M.R., Harman S.M., Resnick S.M. Free testosterone and risk for Alzheimer disease in older men. Neurology 2004, 62:188-193.
38. Morley J.E., Perry H.M. Androgen deficiency in aging men. Med. Clin. North Am. 1999, 83:1279-1289.
39. Morley J.E., Kumar V.B., Bernardo A.E., Farr S.A., Uezu K., Tumosa N., Flood J.F. β-Amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 2000, 21:1761-1767.
40. Morley J.E., Farr S.A., Flood J.F. Antibody to amyloid β protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice. Neurobiol. Learn. Mem. 2002, 78:125-138.
41. Morris J.C. Early-stage and preclinical Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2005, 19:163-165.
42. Morris P.D., Channer K.S. Testosterone and cardiovascular disease in men. Asian J. Androl. 2012, 14:428-435.
43. Neves G., Cooke S.F., Bliss T.V. Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat. Rev. Neurosci. 2008, 9:65-75.
44. Nomura Y., Ohkuma Y. Age-related defects in life span and learning ability in SAMP8 mice. Neurobiol. Aging 1999, 20:111-115.
45. Nomura Y., Wang B.X., Qi S.B., Namba T., Kaneko S. Biochemical changes related to aging in the senescence-accelerated mouse. Exp. Gerontol. 1989, 24:49-55.
46. Paoletti A.M., Congia S., Lello S., Tedde D., Orrù M., Pistis M., Pilloni M., Zedda P., Loddo A., Melis G.B. Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology 2004, 62:301-303.
47. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56:303-308.
48. Petersen R.C. Mild cognitive impairment: current research and clinical implications. Semin. Neurol. 2007, 27:22-31.
49. Pike C.J., Carroll J.C., Rosario E.R., Barron A.M. Protective actions of sex steroid hormones in Alzheimer's disease. Front. Neuroendocrinol. 2009, 30:239-258.
50. Reisberg B., Ferris S.H., de Leon M.J., Franssen E.S.E., Kluger A., Mir P., Borenstein J., George A.E., Shulman E., Steinberg G., Cohen J. Stage-specific behavioral, cognitive, and in vivo changes in community residing subjects with age-associated memory impairment (AAMI) and primary degenerative dementia of the Alzheimer type. Drug Dev. Res. 1988, 15:101-114.
51. Rosario E.R., Pike C.J. Androgen regulation of β-amyloid protein and the risk of Alzheimer's disease. Brain Res. Rev. 2008, 57:444-453.
52. Rossler M., Zarski R., Bohl J., Ohm T.G. Stage-dependent and sectorspecific neuronal loss in hippocampus during Alzheimer's disease. Acta Neuropathol. 2002, 103:363-369.
53. Schott J.M., Kennedy J., Fox N.C. New developments in mild cognitive impairment and Alzheimer's disease. Curr. Opin. Neurol. 2006, 19:552-558.
54. Seidman S.N. Androgens and the aging male. Psychopharmacol. Bull. 2007, 40:205-218.
55. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
56. Sheffield-Moore M., Urban R.J. An overview of the endocrinology of skeletal muscle. Trends Endocrinol. Metab. 2004, 15:110-115.
57. Simić G., Kostović I., Winblad B., Bogdanović N. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J. Comp. Neurol. 1997, 379:482-494.
58. Sperling R.A., Aisen P.S., Beckett L.A., Bennett D.A., Craft S., Fagan A.M., Iwatsubo T., Jack C.R., Kaye J., Montine T.J., Park D.C., Reiman E.M., Rowe C.C., Siemers E., Stern Y., Yaffe K., Carrillo M.C., Thies B., Morrison-Bogorad M., Wagster M.V., Phelps C.H. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:280-292.
59. Takeda T., Hosokawa M., Takeshita S., Irino M., Higuchi K., Matsushita T., Tomita Y., Yasuhira K., Hashimoto H., Shimizu K., Ishii M., Yamamura T. A new murine model of accelerated senescence. Mech. Aging Dev. 1981, 17:183-194.
60. Takeda T., Hosokawa M., Higuchi K. Senescence accelerated mouse (SAM): a novel murine model of accelerated senescence. J. Am. Geriatr. Soc. 1991, 39:911-919.
61. Tan R.S., Pu S.J. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease. Aging Male 2003, 6:13-17.
62. Tan R.S., Pu S.J., Culberson J.W. Role of androgens in mild cognitive impairment and possible interventions during andropause. Med. Hypotheses 2004, 62:14-18.
63. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991, 30:572-580.
64. van de Pol L.A., Hensel A., Barkhof F., Gertz H.J., Scheltens P., van der Flier W.M. Hippocampal atrophy in Alzheimer disease: age matters. Neurology 2006, 66:236-238.
65. Voyer D., Voyer S., Bryden M.P. Magnitude of sex differences in spatial abilities: a meta-analysis and consideration of critical variables. Psychol. Bull. 1995, 117:250-270.
66. West M.J., Coleman P.D., Flood D.G., Troncoso J.C. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994, 344:769-772.
67. West M.J., Kawas C.H., Stewart W.F., Rudow G.L., Troncoso J.C. Hippocampal neurons in pre-clinical Alzheimer's disease. Neurobiol. Aging 2004, 25:1205-1212.
68. Yaari R., Corey-Bloom J. Alzheimer's disease. Semin. Neurol. 2007, 27:32-41.
69. Yagi H., Katoh S., Akiguchi I., Takeda T. Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory. Brain Res. 1988, 474:86-93.
70. Yao M., Nguyen T.V., Rosario E.R., Ramsden M., Pike C.J. Androgens regulate neprilysin expression: role in reducing beta-amyloid levels. J. Neurochem. 2008, 105:2477-2488.
71. Yeap B.B. Testosterone and ill-health in aging men. Nat. Clin. Pract. Endocrinol. Metab. 2009, 5:113-121.
72. Yeap B.B. Are declining testosterone levels a major risk factor for ill-health in aging men?. Int. J. Impot. Res. 2009, 21:24-36.